Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen Davies

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 25, 2003
Construction of an rtTA2(s)-m2/tts(kid)-based transcription regulatory switch that displays no basal activity, good inducibility, and high responsiveness to doxycycline in mice and non-human primatesStefania Lamartina, Luisa Silvi, Giuseppe Roscilli, et al.
Journal of Virology|November 25, 2005
Cytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaquesAdrian B McDermott, David H O'Connor, Sarah Fuenger, et al.
Virology|March 9, 2004
The impact of early immune destruction on the kinetics of postacute viral replication in rhesus monkey infected with the simian-human immunodeficiency virus 89.6PZhi-Qiang Zhang, William A Schleif, Danilo R Casimiro, et al.
Human Gene Therapy|March 17, 2004
Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene: application in epidemiologic studies and in the design of adenovector vaccinesMiguel Aste-Amézaga, Andrew J Bett, Fubao Wang, et al.
Journal of Virology|November 20, 2002
Mamu-A*01 allele-mediated attenuation of disease progression in simian-human immunodeficiency virus infectionZhi-Qiang Zhang, Tong-Ming Fu, Danilo R Casimiro, et al.
JBI Evidence Synthesis|February 3, 2026
Evidence synthesis methodology for questions relating to barriers and enablers in health care: a scoping reviewCindy Stern, Chelsea Valenzuela, Ashley Whitehorn, et al.
Journal of Virology|December 12, 2001
Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol geneDanilo R Casimiro, Aimin Tang, Helen C Perry, et al.
Vaccine|August 7, 2004
Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeysJiang Fan, Xiaoping Liang, Melanie S Horton, et al.
BMJ Open|August 4, 2025
Prioritising methodological research questions for scoping reviews, mapping reviews and evidence and gap maps for health research: a protocol for PROSPECT Delphi studyDanielle Pollock, Sabira Hasanoff, Grace McBride, et al.
Journal of Virology|September 15, 2005
Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeysXiaoping Liang, Danilo R Casimiro, William A Schleif, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 25, 2003
Construction of an rtTA2(s)-m2/tts(kid)-based transcription regulatory switch that displays no basal activity, good inducibility, and high responsiveness to doxycycline in mice and non-human primatesStefania Lamartina, Luisa Silvi, Giuseppe Roscilli, et al.
Journal of Virology|November 25, 2005
Cytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaquesAdrian B McDermott, David H O'Connor, Sarah Fuenger, et al.
Virology|March 9, 2004
The impact of early immune destruction on the kinetics of postacute viral replication in rhesus monkey infected with the simian-human immunodeficiency virus 89.6PZhi-Qiang Zhang, William A Schleif, Danilo R Casimiro, et al.
Human Gene Therapy|March 17, 2004
Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene: application in epidemiologic studies and in the design of adenovector vaccinesMiguel Aste-Amézaga, Andrew J Bett, Fubao Wang, et al.
Journal of Virology|November 20, 2002
Mamu-A*01 allele-mediated attenuation of disease progression in simian-human immunodeficiency virus infectionZhi-Qiang Zhang, Tong-Ming Fu, Danilo R Casimiro, et al.
JBI Evidence Synthesis|February 3, 2026
Evidence synthesis methodology for questions relating to barriers and enablers in health care: a scoping reviewCindy Stern, Chelsea Valenzuela, Ashley Whitehorn, et al.
Journal of Virology|December 12, 2001
Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol geneDanilo R Casimiro, Aimin Tang, Helen C Perry, et al.
Vaccine|August 7, 2004
Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeysJiang Fan, Xiaoping Liang, Melanie S Horton, et al.
BMJ Open|August 4, 2025
Prioritising methodological research questions for scoping reviews, mapping reviews and evidence and gap maps for health research: a protocol for PROSPECT Delphi studyDanielle Pollock, Sabira Hasanoff, Grace McBride, et al.
Journal of Virology|September 15, 2005
Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeysXiaoping Liang, Danilo R Casimiro, William A Schleif, et al.
Pageof 5